Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design.

Autor: VanBuskirk KM; Seattle Biomedical Research Institute, Seattle, WA 98109, USA., O'Neill MT, De La Vega P, Maier AG, Krzych U, Williams J, Dowler MG, Sacci JB Jr, Kangwanrangsan N, Tsuboi T, Kneteman NM, Heppner DG Jr, Murdock BA, Mikolajczak SA, Aly AS, Cowman AF, Kappe SH

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2009 Aug 04; Vol. 106 (31), pp. 13004-9. Date of Electronic Publication: 2009 Jul 22.

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults.

Autor: Kester KE; Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA. kent.kester@na.amedd.army.mil, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG Jr, Hall T, Wellde BT, White K, Sun P, Schwenk R, Krzych U, Delchambre M, Voss G, Dubois MC, Gasser RA Jr, Dowler MG, O'Brien M, Wittes J, Wirtz R, Cohen J, Ballou WR

Publikováno v: Vaccine [Vaccine] 2007 Jul 20; Vol. 25 (29), pp. 5359-66. Date of Electronic Publication: 2007 May 30.